Detalhe da pesquisa
1.
Generation of a humanized mAce2 and a conditional hACE2 mouse models permissive to SARS-COV-2 infection.
Mamm Genome
; 35(2): 113-121, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38488938
2.
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.
Sci Transl Med
; 16(738): eadi0979, 2024 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38478629
3.
Protective Efficacy of Novel Engineered Human ACE2-Fc Fusion Protein Against Pan-SARS-CoV-2 Infection In Vitro and in Vivo.
J Med Chem
; 66(24): 16646-16657, 2023 12 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38100534
4.
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta.
Front Immunol
; 14: 1135815, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36969239
5.
Efficacy and self-similarity of SARS-CoV-2 thermal decontamination.
J Hazard Mater
; 429: 127709, 2022 05 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35086724
6.
Self-Masked Aldehyde Inhibitors of Human Cathepsin L Are Potent Anti-CoV-2 Agents.
Front Chem
; 10: 867928, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35860632
7.
A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.
mBio
; 13(4): e0182222, 2022 08 30.
Artigo
Inglês
| MEDLINE | ID: mdl-35900097
8.
The DNA glycosylase NEIL2 plays a vital role in combating SARS-CoV-2 infection.
Res Sq
; 2022 May 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35665009
9.
A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells.
ACS Chem Biol
; 16(4): 642-650, 2021 04 16.
Artigo
Inglês
| MEDLINE | ID: mdl-33787221
10.
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2.
bioRxiv
; 2020 Nov 17.
Artigo
Inglês
| MEDLINE | ID: mdl-33236012
11.
A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells.
bioRxiv
; 2020 Oct 30.
Artigo
Inglês
| MEDLINE | ID: mdl-33140046